Skip to content

Clinical trials

Phase 1/2 Testicular Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Testicular Neoplasms Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20062
20081
20161
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
University of Arizona2
City of Hope Medical Center1
Duke University1
Fred Hutchinson Cancer Center1
Ludwig Institute for Cancer Research1
National Institutes of Health Clinical Center (CC)1
Temple University1
University of Southampton1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Testicular Neoplasms12
Ovarian Neoplasms9
Central Nervous System Neoplasms4
Kidney Neoplasms4
Neuroblastoma4
Breast Neoplasms3
Burkitt Lymphoma3
Lymphoma3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, T-Cell, Cutaneous3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.